Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Immunome Inc (IMNM)

Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, KLR, IMNM PR Newswire - Tue Sep 12, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AEL : 56.47 (+0.55%)
KLR : 7.24 (-0.14%)
IMNM : 11.70 (-4.10%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMNM, CPRI, AVID PR Newswire - Wed Aug 16, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

IMNM : 11.70 (-4.10%)
CPRI : 33.43 (-1.44%)
AVID : 27.04 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WMC, SGTX, AJX, IMNM PR Newswire - Tue Jul 18, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

WMC : 9.18 (+4.44%)
SGTX : 22.47 (-2.56%)
AJX : 3.42 (-2.29%)
IMNM : 11.70 (-4.10%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, WMC, IMNM, AJX PR Newswire - Mon Jul 10, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

KDNY : 40.39 (+0.22%)
WMC : 9.18 (+4.44%)
IMNM : 11.70 (-4.10%)
AJX : 3.42 (-2.29%)
IMPORTANT ALERT: Halper Sadeh LLC Investigates DICE, IMNM, AJX PR Newswire - Mon Jul 3, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

DICE : 47.55 (+0.06%)
IMNM : 11.70 (-4.10%)
AJX : 3.42 (-2.29%)
Shareholder Alert: Ademi LLP investigates whether Immunome, Inc. has obtained a Fair Price in its Private Placement and its transaction with Morphimmune PR Newswire - Fri Jun 30, 2023

/PRNewswire/ -- Ademi LLP is investigating Immunome (Nasdaq: IMNM) for possible breaches of fiduciary duty and other violations of law in its private placement...

IMNM : 11.70 (-4.10%)
Immunome (NASDAQ: IMNM) and Morphimmune Announce Merger to Develop Best-in-Class Targeted Cancer Therapies Spotlight Growth - Thu Jun 29, 2023

Immunome (Nasdaq: IMNM), a biopharmaceutical company specializing in antibody therapeutics, and Morphimmune, a biotech firm known for targeted oncology therapeutics, have entered into a definitive merger...

PFE : 27.83 (-1.38%)
IMNM : 11.70 (-4.10%)
Immunome Reports First Quarter 2023 Financial Results Business Wire - Fri May 5, 2023

Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics to improve patient care, today reported...

IMNM : 11.70 (-4.10%)
Immunome Reports Fourth Quarter and Full Year 2022 Financial Results Business Wire - Thu Mar 16, 2023

Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics to improve patient care, today reported...

IMNM : 11.70 (-4.10%)
Immunome to Present at 13th Annual World ADC London Conference Business Wire - Thu Mar 9, 2023

Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop antibody therapeutics to improve patient care, today announced that Matthew...

IMNM : 11.70 (-4.10%)

Barchart Exclusives

Is This Copper Mining Stock a Buy for Its Fat Dividend? Barchart - Tue Jul 2, 6:30PM CDT
Southern Copper has a higher dividend yield compared to other copper mining companies. However, its valuations are also on the higher side, making a closer examination of the risk-reward necessary for prospective investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot